| Reference | Country | Diagnostic system | Schizophrenia diagnosis | Duration of schizophrenia | Setting | Mean age | Sample size (males/females) | Period of diagnosis | Type of diagnosis | Prevalence |
|---|---|---|---|---|---|---|---|---|---|---|
| Addington & Addington 2007 Abstract Comments |
Canada | DSM-IV | broad, 79% narrow | First episode | inpatients | 25 | 300 (est. 210/est. 90) (INT: 300) |
lifetime | abuse/dependence | 13.7% (WAP: 13.70%) |
| Akvardar et al. 2004 Abstract Comments |
Turkey | DSM-IV | narrow | 16.0 | in-/outpatients | 39.3 | 49 (26/23) (INT: 49) |
lifetime | abuse, dependence | 2.0% 0.0% (WAP: 2.00%) |
| Altamura et al. 2003 Abstract Comments |
Italy | DSM-III-R | broad, 92% narrow | 18.8 | outpatients | 38 | 81 (55/26) (INT: 81) |
lifetime | abuse/dependence | 4.9% (WAP: 4.90%) |
| Barbee et al. 1989 Abstract |
Afghanistan | DSM-II / DIS | narrow | - | outpatients | - | 53 (35/18) (INT: 53) |
lifetime | abuse, dependence | 35.8% (marijuana) (WAP: 35.80%) |
| Barnett et al. 2007 Abstract Comments |
Afghanistan | DSM-IV | narrow | First episode | outpatients | 0 | 36 (?/?) (INT: 36) |
lifetime | abuse, dependence | 16.7% 36.1% (WAP: 36.10%) |
| Bersani et al. 2002 Abstract Comments |
Italy | DSM-IV | narrow | 10.3 | inpatients | 32.4 | 125 (125/0) (INT: 125) |
current | abuse | 26.0% (WAP: 26.00%) |
| Breakey et al. 1974 Abstract |
- | Other | narrow | - | inpatients | - | 46 (28/18) (INT: 46) |
lifetime | abuse | 45.0% (marijuana) 17.5% (hashish) (WAP: 45.00%) |
| Cantor-Graae et al. 2001 Abstract Comments |
Sweden | DSM-IV | narrow | 21.0 | in-/outpatients | 48 | 87 (54/33) (INT: 87) |
lifetime | abuse | 17.2% (WAP: 17.20%) |
| Carr et al. 2002 Abstract Comments |
Australia | ICD-10 | broad | 14.7 | inpatients | 37.8 | 537 (350/187) (INT: 537) |
lifetime | abuse/dependence | 30.0% (WAP: 30.00%) |
| Cohen & Klein 1970 Abstract |
- | Other | narrow | - | inpatients | - | 24 (?/?) (INT: 24) |
lifetime | abuse | 12.5% (WAP: 12.50%) |
| Compton et al. 2004 Abstract Comments |
USA | DSM-IV | broad, 67% narrow | First episode | inpatients | 20 | 18 (16/2) (INT: 18) |
lifetime | dependence | 44.4% (WAP: 44.40%) |
| Compton et al. 2005 Abstract Comments |
USA | DSM-IV | broad, 64% narrow | - | in-/outpatients | 42.9 | 248 (153/95) (INT: 248) |
lifetime | abuse/dependence | 6.3% (WAP: 6.30%) |
| Compton et al. 2006 Abstract Comments |
Afghanistan | DSM-IV | broad, 40% narrow | First episode | inpatients | 22.8 | 25 (19/6) (INT: 25) |
lifetime | abuse, dependence | 8.0% 40.0% (WAP: 40.00%) |
| Cuffel et al. 1993 Abstract |
United States | in-/outpatients | 231 (/) (INT: 0) |
lifetime | abuse/dependence | 23.0% (WAP: 23.00%) |
||||
| De Haan et al. 2007 Abstract Comments |
Netherlands | DSM-IV | broad, 86% narrow | First episode | in-/outpatients | 20.9 | 119 (96/23) (INT: 119) |
lifetime | abuse/dependence | 31.9% (WAP: 31.90%) |
| DeQuardo et al. 1994 Abstract |
United States | inpatients | 67 (42/25) (INT: 0) |
lifetime | abuse/dependence | 28.4% (WAP: 28.40%) |
||||
| Dervaux et al. 2001 Abstract Comments |
France | DSM-III-R | broad, 91% narrow | - | in-/outpatients | 34.7 | 100 (68/32) (INT: 100) |
lifetime | abuse/dependence | 27.0% (WAP: 27.00%) |
| Deshmukh et al. 2002 Abstract Comments |
Afghanistan | DSM-III-R or ?IV | narrow | - | in-/outpatients | 31.6 | 34 (34/0) (INT: 34) |
lifetime | abuse, dependence | 11.8% 23.5% (both 35.3%) (WAP: 35.30%) |
| Dixon et al. 1991 Abstract |
United States | inpatients | 83 (/) (INT: 0) |
lifetime | abuse/dependence | 31.3% (WAP: 31.30%) |
||||
| Dubertret et al. 2006 Abstract Comments |
France | DSM-IV | narrow | 11.3 | inpatients | 0 | 205 (139/66) (INT: 205) |
lifetime | abuse/dependence | 32.2% (WAP: 32.20%) |
| Farrelly et al. 2007 Abstract Comments |
Australia | DSM-III-R | broad, 46% narrow | First episode | inpatients | 21.7 | 91 (?/?) (INT: 91) |
current | abuse/dependence | 28.6% (WAP: 28.60%) |
| Fowler et al. 1998 Abstract Comments |
Australia | DSM-III-R | narrow | 12.7 | outpatients | 36.3 | 194 (141/53) (INT: 194) |
lifetime, current | abuse, dependence | 7.7% 28.3 (lt) 4.1% 8.8% (c) (WAP: 7.70%) |
| Gearon & Bellack 2000 Abstract Comments |
USA | DSM-IV | narrow | 16.2 | outpatients | 38.3 | 67 (38/29) (INT: 67) |
lifetime | abuse/dependence | 41.0% (WAP: 41.00%) |
| Gut-Fayand et al. 2001 Abstract Comments |
France | DSM-III-R | broad, 96% narrow | 33.2 | in-/outpatients | 33.2 | 50 (32/18) (INT: 50) |
lifetime | abuse, dependence | 6.0% 8.0% (WAP: 8.00%) |
| Hambrecht & Häfner 1996 Abstract |
Germany | First episode | 232 (/) (INT: 0) |
lifetime | abuse/dependence | 13.0% (WAP: 13.00%) |
||||
| Hides et al. 2007 Abstract Comments |
Australia | DSM-IV | broad | appr. 9.4 | inpatients | 30 | 142 (102/40) (INT: 142) |
current | dependence | 53.5% (WAP: 53.50%) |
| Holthausen et al. 2002 Abstract Comments |
Netherlands | DSM-IV | broad | First episode | inpatients | 24.8 | 118 (87/31) (INT: 118) |
current | abuse | 48.3% (WAP: 48.30%) |
| Kamali et al. 2000 Abstract Comments |
Ireland | DSM-IV | broad | 15.1 | inpatients | 38.4 | 102 (68/34) (INT: 102) |
lifetime, current | abuse/dependence | 16.7% 17.6% (WAP: 17.60%) |
| Karam et al. 2002 Abstract Comments |
Lebanon, Israel | DSM-III-R | narrow | - | inpatients | 34.5 | 18 (12/6) (INT: 18) |
lifetime | abuse | 44.4% (WAP: 44.40%) |
| Katz et al. 2008 Abstract Comments |
Israel | DSM-IV | broad | - | in-/outpatients | 0 | 227 (?/?) (INT: 227) |
lifetime | abuse | 11.9% (WAP: 11.90%) |
| Kavanagh et al. 2004 Abstract Comments |
Australia | DSM-III-R | narrow | - | in-/outpatients | 0 | 430 (?/?) (INT: 430) |
lifetime | abuse/dependence | 26.5% (WAP: 26.50%) |
| Kirkpatrick et al. 1996 Abstract Comments |
Afghanistan | DSM-IV | narrow | 11.3 | in-/outpatients | 34.4 | 122 (lifetime), 154 (current) (84 (lt), 103 (c)/38 (lt), 51 (c)) (INT: 276) |
lifetime, current | abuse/dependence | 12.3% 1.9% (WAP: 12.30%) |
| Kovasznay et al. 1997 Abstract |
United States | First episode | 96 (54/42) (INT: 0) |
lifetime | abuse/dependence | 30.2% (WAP: 30.20%) |
||||
| Magliozzi et al. 1983 Abstract |
- | DSM-III | narrow | - | inpatients | - | 57 (57/0) (INT: 57) |
current | use | 42.0% (WAP: 42.00%) |
| Margolese et al. 2004 Abstract Comments |
Canada | DSM-IV | broad, 62% narrow | First episode | outpatients | 38.8 | 207 (120/87) (INT: 207) |
current | abuse/dependence | 8.2% (WAP: 8.20%) |
| Modestin et al. 2001 Abstract Comments |
Switzerland | ICD-10 | narrow | 13.2 | in-/outpatients | 40.6 | 525 (est. 278/est. 247) (INT: 525) |
lifetime | harmful use/dependence | 12.0% (WAP: 12.00%) |
| Moilanen et al. 2003 Abstract Comments |
Finland | DSM-III-R | narrow | 9.3 | in-/outpatients | 0 | 96 (63/33) (INT: 96) |
lifetime | abuse/dependence | 0.0% (WAP: 0.00%) |
| Mueser et al. 2000 Abstract Comments |
USA | DSM-III-R | broad, 51% narrow | - | inpatients | 38.8 | 173 (154/19) (INT: 173) |
lifetime | abuse/dependence | 27.2% (WAP: 27.20%) |
| Mueser et al. 1990 Abstract |
United States | inpatients | 149 (95/54) (INT: 0) |
lifetime | abuse/dependence | 42.0% (WAP: 42.00%) |
||||
| Mueser et al. 1992 Abstract |
United States | inpatients | 159 (/) (INT: 0) |
lifetime | abuse/dependence | 15.7% (WAP: 15.70%) |
||||
| Negrete et al. 1986 Abstract |
- | ICD-9 | narrow | - | outpatients | - | 137 (82/55) (INT: 137) |
lifetime, current | use | 55.5% 18.2% (WAP: 55.50%) |
| Peralta & Cuesta 1992 Abstract |
Spain | inpatients | 95 (63/32) (INT: 0) |
current | abuse/dependence | 24.0% (WAP: 24.00%) |
||||
| Rabinowitz et al. 1998 Abstract Comments |
USA | DSM-III-R | not reported | First episode | inpatients | 0 | 224 (146/78) (INT: 224) |
lifetime | abuse/dependence | 31.3% (WAP: 31.30%) |
| Röder-Wanner & Priebe 1998 Abstract |
Germany | First episode | 90 (30/60) (INT: 0) |
lifetime | abuse/dependence | 18.9% (WAP: 18.90%) |
||||
| Siris et al. 1988 Abstract |
- | RDC, SADS | broad | - | outpatients | - | 46 (24/22) (INT: 46) |
lifetime | abuse | 35.0% (marijuana) (WAP: 35.00%) |
| Verdoux et al. 2001 Abstract Comments |
France | DSM-IV | broad, 44% narrow | First episode | inpatients | 31 | 27 (15/12) (INT: 27) |
lifetime | abuse/dependence | 18.5% (WAP: 18.50%) |
| Wade et al. 2005 Abstract Comments |
Australia | DSM-III-R | not reported | First episode | inpatients | 21.3 | 93 (68/25) (INT: 93) |
lifetime | abuse/dependence | 65.6% (WAP: 65.60%) |
| Wobrock et al. 2007 Abstract Comments |
Germany | ICD-10 | not reported | First episode | inpatients | 25.7 | 68 (est. 45/est. 23) (INT: 68) |
lifetime | harmful use | 45.6% (WAP: 45.60%) |
| Xafenias et al. 2008 Abstract Comments |
Greece | DSM-IV | not reported | - | inpatients | 0 | 105 (?/?) (INT: 105) |
current | abuse/dependence | 8.6% (WAP: 8.60%) |
| Ziedonis & Trudeau 1997 Abstract Comments |
USA | DSM-III-R | broad, 64% narrow | - | outpatients | 44 | 497 (253/244) (INT: 497) |
current | abuse | 14.3% (WAP: 14.30%) |